iSpecimen Inc. Increase Decrease In Operating Lease Liability
iSpecimen Inc. (ISPC) reported Increase Decrease In Operating Lease Liability of -$27.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- iSpecimen Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$14.09K.
- iSpecimen Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$13.81K.
- iSpecimen Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$12.64K.
- iSpecimen Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$6.45K.
- iSpecimen Inc. increase decrease in operating lease liability for fiscal 2025 was -$43.37K.
- iSpecimen Inc. increase decrease in operating lease liability for fiscal 2024 was -$120.20K.
- iSpecimen Inc. increase decrease in operating lease liability for fiscal 2023 was -$155.96K.
- iSpecimen Inc. increase decrease in operating lease liability for fiscal 2022 was -$147.28K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$27.89K 10-Q · filed 2026-08-14 | -$40.53K derived: sum of 3 quarters · filed 2026-08-14 | -$46.98K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$13.81K 10-Q · filed 2026-05-18 | -$26.45K derived: sum of 2 quarters · filed 2026-05-18 | -$32.90K derived: sum of 3 quarters · filed 2026-05-18 | -$45.16K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$12.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$19.09K derived: sum of 2 quarters · filed 2026-04-01 | -$31.35K derived: sum of 3 quarters · filed 2026-08-14 | -$43.37K 10-K · filed 2026-04-01 |
| 2025-09-30 | -$6.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$18.71K derived: sum of 2 quarters · filed 2026-08-14 | -$30.73K 10-Q · filed 2025-11-17 | -$42.51K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$12.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$24.28K 10-Q · filed 2026-08-14 | -$36.06K derived: sum of 3 quarters · filed 2026-08-14 | -$63.05K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$12.02K 10-Q · filed 2026-05-18 | -$23.80K derived: sum of 2 quarters · filed 2026-05-18 | -$50.79K derived: sum of 3 quarters · filed 2026-05-18 | -$92.68K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$11.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$38.77K derived: sum of 2 quarters · filed 2026-04-01 | -$80.66K derived: sum of 3 quarters · filed 2026-04-01 | -$120.20K 10-K · filed 2026-04-01 |
| 2024-09-30 | -$26.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$68.88K derived: sum of 2 quarters · filed 2025-11-17 | -$108.42K 10-Q · filed 2025-11-17 | -$312.88K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$41.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$81.44K 10-Q · filed 2025-08-14 | -$285.89K derived: sum of 3 quarters · filed 2025-08-14 | -$159.52K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$39.54K 10-Q · filed 2025-05-19 | -$244.00K derived: sum of 2 quarters · filed 2025-05-19 | -$117.63K derived: sum of 3 quarters · filed 2025-05-19 | -$157.03K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$204.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$78.09K derived: sum of 2 quarters · filed 2025-04-14 | -$117.49K derived: sum of 3 quarters · filed 2025-04-14 | -$155.96K 10-K · filed 2025-04-14 |
| 2023-09-30 | $126.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $86.97K derived: sum of 2 quarters · filed 2024-11-07 | $48.49K 10-Q · filed 2024-11-07 | $10.76K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$39.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$77.87K 10-Q · filed 2024-08-06 | -$115.61K derived: sum of 3 quarters · filed 2024-08-06 | -$152.78K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$38.47K 10-Q · filed 2024-05-07 | -$76.20K derived: sum of 2 quarters · filed 2024-05-07 | -$113.38K derived: sum of 3 quarters · filed 2024-05-07 | -$150.01K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$37.73K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$74.91K derived: sum of 2 quarters · filed 2024-03-13 | -$111.53K derived: sum of 3 quarters · filed 2024-03-13 | -$147.28K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$37.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$73.80K derived: sum of 2 quarters · filed 2023-11-02 | -$109.54K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$36.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$72.37K 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$35.74K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |